Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| C Provides AI platform for enterprise travel and expense management | $11.5M | Series A | AI | United States | Investors | |
| Q |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
Develops control systems for quantum computing experiments
Develops control systems for quantum computing experiments
| €162K |
| Undisclosed |
| Hardware |
| Switzerland |
| Investors |
| vH vVARDIS HoldingCompany profile Develops non-invasive peptide-containing formulations to treat tooth decay Develops non-invasive peptide-containing formulations to treat tooth decay | Undisclosed | StrategicUndisclosed | Healthtech | Switzerland | Investors |
| P Develops intracoronary liquid biopsy for cardiovascular disease | $5M | Undisclosed | Biotech | United Kingdom | Investors Undisclosed |
| S Provider of physical AI for warehouse robotics | $110M | Series B | Robotics | Germany | Investors |
| FP Four PillarsCompany profile Provides blockchain research, technology, and validator infrastructure services Provides blockchain research, technology, and validator infrastructure services | Undisclosed | Series A | Fintech | South Korea | Investors |
| FT Uses quantum chemistry and AI to design novel drug molecules | $47M | Series A | Biotech | United States | Investors |
| N NervonikCompany profile Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions Develops peripheral nerve stimulation technologies for chronic pain and neurological conditions | $52.5M | Series B | Healthtech | United States | Investors |
| II Building an AI system that learns autonomously | $1.1B | Seed | AI | United Kingdom | Investors |
| S SquareMindCompany profile Develops AI and robotics solutions for dermatology, specifically skin exams and skin imaging Develops AI and robotics solutions for dermatology, specifically skin exams and skin imaging | $18M | Pre-Series AUndisclosed | Healthtech | France | Investors |